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STUDY QUESTION: Does endothelin-1 (ET-1) regulate matrix metalloproteinase (MMP) 14 and 15 production and invasion of human
ﬁrst trimester trophoblasts?
SUMMARY ANSWER: ET-1 in pathophysiological concentrations down-regulates MMP14 and MMP15 expression via endothelin receptor
(ETR) type B and decreases trophoblast migration and invasion.
WHAT IS KNOWN ALREADY: MMP14 and MMP15 are involved in trophoblast invasion. Impairment of invasion has been linked to
pregnancy complications such as pre-eclampsia (PE). ET-1 is up-regulated in PE.
STUDY DESIGN, SIZE, DURATION: In vitro study using primary human trophoblasts from 50 ﬁrst trimester placentas (gestational week
7–12).
PARTICIPANTS/MATERIALS, SETTING, METHODS: Trophoblasts were cultured in the absence or presence of 10–100 nM ET-1.
MMP14 and MMP15 mRNA and protein were quantiﬁed by RT-qPCR and Western blotting, respectively. Selective antagonists for ETRA
(BQ-123) or ETRB (BQ-788) were used to identify ETR subtypes involved. Functional ET-1 effects were tested in ﬁrst trimester chorionic vil-
lous explants and transwell invasion assays. The roles of tumor necrosis factor (TNF)-α (25 ng/ml) and oxygen (1%) in ET-1 regulation of
MMP14 and 15 expression were assessed by Western blotting.
MAIN RESULTS AND THE ROLE OF CHANCE: ET-1 down-regulated MMP14 and MMP15 mRNA (−21% and −26%, respectively,
P < 0.05) and protein levels (–18% and –22%, respectively, P < 0.05). This effect was mediated via ETRB. ET-1 decreased trophoblast out-
growth in placental explants (−24%, P < 0.05) and trophoblast invasion (−26%, P ≤ 0.01). TNF-α enhanced ET-1 mediated MMP15
down-regulation (by 10%, P < 0.05), whereas hypoxia abolished the effect of ET-1 on both MMPs.
LARGE SCALE DATA: N/A.
LIMITATIONS, REASONS FOR CAUTION: Only primary trophoblasts were used in this study. Since trophoblast yield from ﬁrst tri-
mester placental material is limited, further aspects of MMP14 and 15 regulation could not be characterized. Other anti-invasive factors may
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be altered by ET-1 in trophoblasts and, thus, contribute to the reduced invasion, but have not been investigated. Oxygen levels similar to
those found in the decidua (5–8% O2) were not analyzed in this study.
WIDER IMPLICATIONS OF THE FINDINGS: ET-1 modiﬁes placental function already during the ﬁrst trimester of pregnancy, the
time-window when the placental changes implicated in PE occur. Thus, our results improve the understanding of the placental mechanisms
underlying trophoblast invasion and PE.
STUDY FUNDING/COMPETING INTEREST(S): The study was funded by the Oesterreichische Nationalbank (Anniversary Fund,
project number: 14796) and the Herzfelder’sche Familienstiftung (to J.P.; number: 00685). AMM received funding from the Austrian Science
Fund FWF (W1241) and the Medical University Graz through the PhD Program Molecular Fundamentals of Inﬂammation (DK-MOLIN). The
authors have no conﬂict of interest.
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Introduction
During the ﬁrst trimester of pregnancy trophoblast differentiates along
two pathways: (i) villous trophoblast (VT), and (ii) extravillous tropho-
blast (EVT). VT are proliferative cells which can fuse to form the syncy-
tiotrophoblast, a multinucleated layer involved in nutrient and oxygen
transportation and hormone production. EVT are invasive cells which
migrate from the tip of the placental villi and invade the uterine wall
(Knöﬂer, 2010). EVT also reach and remodel the spiral arteries, trans-
forming them into low resistance vessels, a process necessary to allow
an adequate blood supply to the fetus (Kaufmann et al., 2003).
EVT migration and invasion, as well as spiral artery remodeling,
require degradation of the extracellular matrix (ECM). For that pur-
pose, trophoblast cells express a variety of proteases, including ser-
ine proteases, cathepsins and matrix metalloproteinases (MMPs)
(Ghaffari-Tabrizi-Wizsy et al., 2014). The latter are a family of 24
zinc-dependent endopeptidases capable of degrading virtually all the
components of the ECM. MMPs are secreted as zymogens contain-
ing a pro-domain, and their activity can be regulated at several
levels, e.g. transcription, activation and inhibition by tissue inhibitors
of MMPs (TIMPs) (Nagase et al., 2006). A subfamily of MMPs are
membrane-type MMPs (MT-MMPs), containing a membrane insert.
These MT-MMPs are important in many aspects of physiology and
pathophysiology of pregnancy (Majali-Martinez et al., 2016). We
and others have shown that in primary ﬁrst trimester trophoblasts
only two members of the MT-MMP subfamily, MMP14 and MMP15
are highly expressed (Hiden et al., 2013), with MMP15 being specif-
ically expressed in EVT (Pollheimer et al., 2014). Moreover, MMP14
and MMP15 are the main activators of MMP2 (Itoh, 2015), a
secreted MMP also known to play a pivotal role in trophoblast inva-
sion (Xu et al., 2000). Therefore, MMP14 and 15 are considered
key players in trophoblast invasion.
Both, MMP expression and trophoblast invasion have to be tightly
regulated to ensure a successful pregnancy. Indeed, pre-eclampsia
(PE) has been linked to an impairment of trophoblast invasion already
in the ﬁrst trimester (Kaufmann et al., 2003). PE occurs in 2–8% of
pregnancies and is one of the major causes of maternal morbidity
and mortality. Thus, current efforts aim to identify biomarkers that
would allow improved management of pregnancies at risk for PE
(Rodriguez et al., 2016).
Endothelin-1 (ET-1) has gained considerable attention in PE research
(George and Granger, 2012). It acts through its two G protein-coupled
receptors, ETR type A (ETRA) and type B (ETRB) (Luscher and Barton,
2000). ET-1 regulates the vascular tone but also modulates prolifer-
ation, migration and invasion of several cell types (Liu et al., 2012;
Chiriboga et al., 2016). In PE, ET-1 is up-regulated due to the endothe-
lial cell dysfunction characteristic of this condition (Lamarca, 2012).
Interestingly, higher maternal ET-1 levels during the ﬁrst trimester have
been related to an increased risk of developing PE later in pregnancy
(Shaarawy and Abdel-Magid, 2000). Moreover, ﬁrst trimester tropho-
blasts secrete ET-1 and express both ETRA and ETRB (Cervar and
Desoye, 1998).
Given the strong role of ET-1, MMP14 and MMP15 in modulating
trophoblast invasion, we hypothesized that ET-1 regulates MMP14 and
MMP15 expression in human primary ﬁrst trimester trophoblasts
entailing functional consequences for trophoblast invasion. The risk of
PE is higher in pro-inﬂammatory conditions such as obesity (Jeyabalan,
2013), and may change oxygen tension in the intervillous space
through delayed or inadequate opening of the spiral arteries (Ouyang
et al., 2009). Therefore, we tested whether a pro-inﬂammatory cyto-
kine, tumor necrosis factor (TNF)-α or hypoxia further modulate the
ET-1 effect on MMP14 and MMP15.
Material and Methods
First trimester trophoblast isolation
The study was approved by the institutional review board and ethical com-
mittee of the Medical University of Graz (24-129 ex 11/12) and the
Medical University of Vienna (084/2009). Signed informed consent was
obtained from the pregnant women. Trophoblasts were isolated from 50
ﬁrst trimester placentas (gestational week (GW) 7–12) after pregnancy
termination for psychosocial reasons as described elsewhere (Blaschitz
et al., 2000). GW was determined by ultrasound measurement of crown-
rump length, and only placentas from similar gestational ages, i.e. early
(GW 7+ 8), mid (GW 9+ 10) or late (GW 11+ 12) ﬁrst trimester, were
pooled before trophoblast isolation when required. Brieﬂy, placental villi
were digested with Dispase/DNAse and Trypsin (Gibco, Invitrogen,
Carlsbad, CA, USA). After Percoll (Gibco) gradient centrifugation, cells
were incubated with magnetic beads conjugated with anti-CD90 and anti-
CD45 (Dako, Glostrup, DK) antibodies for 30 min and placed on a
DynaMag-15 magnet (Thermo Scientiﬁc, Rockford, IL, USA) to remove
ﬁbroblasts and common leukocyte antigen expressing cells. The cells
obtained constituted a mixture of VT and EVT. Functional activity and pur-
ity of trophoblast isolations were assessed by secretion of human chorionic
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gonadotropin (hCG) (Dade Behring, Deerﬁeld, IL, USA) and immunocyto-
chemical staining for cytokeratin 7 (Dako, 1:750) and human leukocyte
antigen (HLA)-G (BD-Biosciences, Bedford, MA, USA, 1:500), respect-
ively. Only functionally active preparations with a purity ≥95% were used.
Cell culture
Isolated trophoblasts were seeded in gelatin pre-coated plates and main-
tained for 2 days in Keratinocyte medium (KCM, Gibco) with penicillin/
streptomycin (Gibco), KCM supplements (Gibco) and 10% (v/v) fetal calf
serum (FCS, Thermo Scientiﬁc) in a humidiﬁed incubator at 37°C, 5% CO2
in air. Prior to treatments, the cells were cultured under low serum condi-
tions (2% (v/v) FCS) for 24 h. Thereafter, the cells were incubated in the
absence (control) or presence of 10 nM or 100 nM ET-1 (Sigma Aldrich,
St. Louis, MO, USA) for 24 h. The ETR subtype involved in mediating ET-1
effects was determined by pre-incubating trophoblasts with selective ETR
antagonists for 2 h prior to the addition of 100 nM ET-1: BQ-123 (Tocris,
Bristol, UK, 1.4 and 11.2 nM) for ETRA and BQ-788 (Tocris, 1.2 and
9.6 nM) for ETRB. Because late ﬁrst trimester (GW 11+ 12) placentas
gave highest trophoblast yields, these isolations were used in this set of
experiments. Trophoblasts were also treated with TNF-α (Sigma Aldrich,
25 ng/ml) either alone or in combination with 100 nM ET-1, or incubated
in the absence or presence of 100 nM ET-1 under three different oxygen
tensions (1%, 2.5% and 20% O2) for 24 h.
RNA isolation and RT-qPCR analysis
Total trophoblast RNA was isolated with the RNeasy mini kit (Qiagen,
Hilden, DE). RNA (250 ng) was reverse transcribed to cDNA using
SuperScript II Reverse Transcriptase (Life Technologies-Invitrogen,
Carlsbad, CA, USA) according to the manufacturer’s guidelines. MMP14
and MMP15 expression was determined by Real-time quantitative PCR
(RT-qPCR) using FAM-labeled TaqMan gene expression assays (Life
Technologies, MMP14: Hs01037003_g1; MMP15: Hs00233997_m1),
TaqMan universal PCR master mix (Life Technologies) and the CFX96
real-time PCR detection system (BioRad Laboratories, Hercules, CA,
USA). Ct values were automatically generated by the BioRad CFX
Manager 3.0 software and relative gene expression was calculated by the
2−ΔΔCt method, with β-actin (Life Technologies, ACTB: Hs01060665_g1)
as the reference gene.
Protein quantiﬁcation byWestern blotting
and ELISA
Lysates of total cell proteins were prepared in RIPA buffer (Sigma Aldrich)
containing protease inhibitors (Roche, Mannheim, DE), mixed with
Laemmli buffer (Sigma Aldrich) and denatured at 96°C for 5 min. Samples
were loaded onto 10% (v/v) SDS-PAGE gels (Bio-Rad Laboratories),
resolved at 140 V for 1 h and transferred to nitrocellulose membranes
(Bio-Rad Laboratories). Non-speciﬁc binding sites were blocked for 1 h
with 5% (w/v) non-fat dry milk (Bio-Rad Laboratories) in tris-buffered
saline (TBS) + 0.1% (v/v) Tween 20 (Sigma Aldrich). After blocking, the
membranes were incubated with antibodies against MMP14 (Millipore,
Billerica, MA, USA, 1:1500), MMP15 (Millipore, 1:500), HLA-G (BD-
Biosciences, 1:1000), GAPDH (Novus, Littleton, CO, USA, 1:20 000) or
β-actin (Abcam, Cambridge, MA, USA, 1:25 000) overnight at 4°C. Blots
were subsequently washed and incubated with the appropriate HRP-
conjugated secondary antibody (Bio-Rad Laboratories, 1:2500 for MMP14,
1:1000 for MMP15; 1:2000 for HLA-G, 1:6000 for GAPDH and 1:25 000
for β-actin). Immunolabeling was detected using SuperSignal West Pico
Chemiluminescent Substrate (Thermo Scientiﬁc) and visualized with the
Chemidoc XRS software (Bio-Rad Laboratories). Band density was quanti-
ﬁed using the Alpha Digidoc software (Alpha Innotech Corp, Innsbruck,
AUT). GAPDH or β-actin were used as loading control.
Cell supernatants from controls under 1%, 2.5% and 20% O2 (5% CO2
balance N2) were collected and concentrated through column centrifuga-
tion (Sartorius Stedim, Goettingen, DE) to a ﬁnal volume of 500 µl. ET-1
concentrations were determined by ELISA according to manufacturer’s
instructions (R&D, Abingdon, UK) and normalized to total protein concen-
tration in the supernatants.
Explants of ﬁrst trimester chorionic villi
First trimester placental explants were prepared following established pro-
tocols (Vicovac et al., 1995). Brieﬂy, small pieces of tissue (2–4 mm2) from
the periphery were dissected under the microscope and maintained in
DMEM/Ham’s F12 medium (Gibco) without serum supplementation.
ECM was prepared by mixing collagen I (Corning, Bedford, MA) with 10×
DMEM (Gibco, 1:10, v/v) and 7.5% sodium bicarbonate (Sigma, 1:5, v/v)
followed by incubation at 37°C for gel formation. The dissected placental
tissue was then placed on the top of the gel and incubated for 4 h for
anchorage. Medium without (control) or with 100 nM ET-1 was subse-
quently added for 24 h. Trophoblast outgrowth was measured as the dis-
tance from the villous margin to the outer edge of the migrating cell layer.
Transwell invasion assay
Trophoblast invasion was determined using 12 mm Transwell inserts with
12 µm pores (Millipore) pre-coated with 1 mg/ml ﬁbronectin (Millipore).
Inserts were placed into a 24-well plate containing 400 µl DMEM/Ham’s
F-12 medium supplemented with 10% (v/v) FCS. After isolation, tropho-
blasts were re-suspended in 300 µl medium without FCS in the absence
(control) or presence of 100 nM ET-1, and seeded in the upper chamber.
After 48 h, the inserts were ﬁxed with ice-cold methanol and non-invading
cells were removed with a cotton swab. Invading cells were stained with
DAPI and ﬁve different ﬁelds were counted under the microscope with a
magniﬁcation of 100×.
Statistics
Statistical analyses were performed using Graphpad (version 6.5). The
results presented are representative for at least three independent experi-
ments. After testing for normal distribution (Kolmogorov-Smirnov and
Shapiro-Wilk), statistical signiﬁcance was determined by t-test or ANOVA
as appropriate, and P < 0.05 was considered statistical signiﬁcant.
Results
ET-1 down-regulates MMP14 and 15 mRNA
and protein levels
ET-1 had a dose-dependent effect on MMP14 and 15 mRNA, with
100 nM ET-1 down-regulating both MMP14 (−21%; P ≤ 0.01) and
MMP15 (−26%; P ≤ 0.001) expression in primary trophoblasts (GW
7+ 8, Fig. 1A).
For protein analysis, samples were divided into early (GW 7+ 8) and
mid (GW 9+ 10) ﬁrst trimester trophoblasts. For MMP14, only the
active form (act-MMP14) was observed, whereas for MMP15, pro-
MMP15 and active-MMP15 (act-MMP15) were detected at the
expected molecular weights (Fig. 1B). In concordance with the mRNA
results, ET-1 dose-dependently reduced act-MMP14 (−18%; P < 0.05)
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and total-MMP15 (sum of pro- and act-MMP15; −22%; P ≤ 0.01) pro-
tein levels in primary trophoblasts from GW 7+ 8. This was also true
for pro- and act-MMP15 when analyzed separately (Fig. 1C). The ET-1
effect on MMP15 (total, pro- and active forms) was maintained in tro-
phoblasts from GW 9+ 10, whereas MMP14 down-regulation showed
a similar tendency without reaching statistical signiﬁcance (Fig. 1D).
MMP14 and 15 down-regulation is mediated
via ETRB
ETR involvement in MMP14 and MMP15 down-regulation was deter-
mined in late ﬁrst trimester primary trophoblasts (GW 11+ 12) using
two speciﬁc antagonists for ETRA and ETRB. We ﬁrstly conﬁrmed the
effect of ET-1 on MMP14 and MMP15 down-regulation (Fig. 2, −21%; P
< 0.05 and −22%; P ≤ 0.01; respectively). Pre-incubation with ETRA
antagonist BQ-123 enhanced the effect of ET-1 on act-MMP14 and
total-MMP15 down-regulation by 16% and 15%, respectively (Fig. 2A–C,
100 nM ET-1 vs 11.2 nM BQ-123 + 100 nM ET-1, P < 0.05), whereas
blocking ETRB with BQ-788 abolished the effect of ET-1 on MMP
down-regulation (Fig. 2D–F). Similar results were obtained when pro-
and act-MMP15 were analyzed separately (Supplementary data, Fig. S1).
Altogether, these results indicate that MMP down-regulation is mediated
via ETRB.
ET-1 hinders trophoblast migration
and invasion
To test whether ET-1 impairs trophoblast function, trophoblast migra-
tion and invasion were determined. First trimester chorionic villi were
cultured in the absence (Fig. 3A) or presence (Fig. 3B) of ET-1 and
trophoblast outgrowth, i.e. migration from the villous margin, was
determined (arrows, Fig. 3A and B). After 24 h, 100 nM ET-1
decreased trophoblast outgrowth by 24% (Fig. 3C; P ≤ 0.01). Since
trophoblast outgrowth reﬂects trophoblast migration, we additionally
performed transwell invasion assays (Fig. 3D). In concordance with
what we observed in the chorionic villi, 100 nM ET-1 decreased inva-
sion of isolated trophoblasts (−26%; P ≤ 0.01).
Figure 1 Endothelin-1 (ET-1) down-regulates matrix metalloproteinase (MMP) 14 and MMP15 mRNA and protein levels in primary trophoblast:
(A) MMP14 and MMP15 expression was determined by RT-qPCR (GW 7+ 8, n = 5); (B–D) For Western blot analysis, trophoblast isolations were
separated according to gestational week (GW 7+ 8, n = 9; and 9+ 10, n = 4); MMP14 (active form, act-MMP14) and MMP15 (pro-MMP15, active:
act-MMP15, total-MMP15: pro+ act-MMP15) were detected; Results were normalized to β-act expression or GAPDH protein levels and calculated as
fold change relative to the controls, arbitrarily set to 1; Data are representative for at least three experiments; n.s., non-signiﬁcant; *P < 0.05, **P ≤
0.01, ***P ≤ 0.001 vs control.
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TNF-α enhances ET-1 mediated MMP15
down-regulation
TNF-α was used to assess whether a pro-inﬂammatory environment
modulates the effect of ET-1 on MMP regulation. Alone, TNF-α had
no effect on act-MMP14 or total-MMP15 protein levels when com-
pared to the controls (Fig. 4). When administered together with ET-1,
TNF-α did not alter the effect of ET-1 on act-MMP14 down-regulation.
In contrast, TNF-α increased the effect of ET-1 on total-MMP15
down-regulation by 10% (Fig. 4, ET-1 vs ET-1+ TNF-α; P < 0.05).
Similar results were obtained when pro- and act-MMP15 were ana-
lyzed separately (Supplementary data, Fig. S2).
Low oxygen tension abolishes the effect
of ET-1 on MMP14 and 15 down-regulation
To determine whether hypoxia (1% O2) modulates MMP14 and 15
levels and their regulation by ET-1, two different control conditions
were used: (i) 2.5% O2 mimicking ﬁrst trimester placental oxygen
levels (Tuuli et al., 2011) and, (ii) 20% O2 since cell isolation was per-
formed under this condition.
When compared to 20% O2, primary trophoblasts cultured under
1% O2 had decreased act-MMP14 (−40%; P ≤ 0.01) and pro-MMP15
(−45%; P ≤ 0.001) protein levels (Fig. 5A–C). No differences were
observed between 1% O2 and 2.5% O2.
Figure 2 MMP14 and MMP15 down-regulation is mediated via endothelin receptor type B (ETRB): Primary trophoblasts (GW 11+ 12, n = 7) were
pre-incubated with two selective ETR antagonists (A–C, BQ-123 for ETRA; D–F, BQ-788 for ETRB) for 2 h prior to the treatment with 100 nM ET-1;
MMP14 (active form, act-MMP14) and MMP15 (pro-MMP15, act: active-MMP15, total-MMP15: pro+ act-MMP15) protein levels were determined by
Western blotting; Results were normalized to GAPDH protein levels and calculated as fold change relative to the controls, arbitrarily set to 1; Data are
representative for at least four experiments; *P < 0.05, **P ≤ 0.01, ***P ≤ 0.001
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Figure 3 ET-1 hinders trophoblast migration and invasion: (A–C) Trophoblast migration was measured as trophoblast outgrowth (arrows, A and B)
from chorionic villi (GW 7–11, n = 4) in the absence (control) or presence of 100 nM ET-1 for 24 h; (D) Trophoblast invasion was determined in trans-
well assays; For both assays results were calculated relative to the controls, arbitrarily set to 1; Data are representative for at least four experiments;
**P ≤ 0.01.
Figure 4 Tumor necrosis factor (TNF)-α enhances the effect of ET-1 on MMP15 down-regulation: Primary trophoblasts (GW 7–11, n = 5) were
incubated in the absence (control) or presence of TNF-α (25 ng/ml) and 100 nM ET-1 either singly or in combination for 24 h; (A) MMP14 (active
form, act-MMP14) and MMP15 (pro-MMP15, act-MMP15, total-MMP15: pro+ act-MMP15) protein levels were determined by Western blotting;
(B) Results were normalized to GAPDH protein levels and calculated as fold change relative to the controls, arbitrarily set to 1; Data are representa-
tive for at least four experiments; *P < 0.05; **P ≤ 0.01.
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The effect of ET-1 on act-MMP14 and pro-MMP15 down-regulation
was abolished under 1% O2 (Fig. 5A–C). Interestingly, under 2.5% O2
the effect of ET-1 on MMP14 down-regulation was also inhibited,
whereas MMP15 down-regulation was increased (−53% under 2.5%
O2 vs −37% under 20% O2, Fig. 5A and C).
To test whether these observations correlate with differences in
endogenous ET-1 production, ET-1 levels were measured in the
supernatants of primary trophoblasts not supplemented with ET-1
(Fig. 5D). ET-1 secretion was signiﬁcantly increased under 1% O2 (+55
and +50% vs 2.5% and 20% O2, respectively, P < 0.05).
Discussion
Despite the increasing number of studies addressing the human pla-
centa during the ﬁrst trimester of pregnancy, the molecular mechanisms
regulating trophoblast invasion are still not completely understood. We
therefore assessed the role of ET-1 on MMP14 and 15 expression, two
key proteases involved in trophoblast invasion (Hiden et al., 2013;
Pollheimer et al., 2014). Our key ﬁndings were that ET-1 reduced
MMP14 and 15 protein levels via ETRB in primary trophoblasts, and
that this effect was paralleled by a decrease in trophoblast invasion.
ET-1 has been described to regulate MMPs in several cell types.
However, these data refer mainly to MMP2 and 9 (Yao et al., 2001).
Here we show that ET-1 down-regulates MMP14 and 15 mRNA and
protein expression in a dose-dependent manner. This effect is not
accounted for by ET-1 affecting trophoblast differentiation, because
HLA-G protein, a classical marker of EVT, was unaltered by the treat-
ment (Supplementary data, Fig. S3).
Interestingly, we only detected the active form of MMP14, whereas
both the pro- and active forms of MMP15 were observed. Since MT-
MMPs are activated by Golgi-associated pro-protein convertases
(PCs) (Golubkov et al., 2007), our data suggest that different mem-
bers of the PC family might be involved in MMP14 and MMP15 activa-
tion. We analyzed the ratio between pro- and active-MMP15 as a
measure of MMP15 activation. This ratio was lowest in primary tro-
phoblasts from mid ﬁrst trimester (GW 9 + 10), suggesting that the
activation of speciﬁc proteases is ﬁne-tuned during the ﬁrst trimester
of pregnancy. However, ET-1 did not alter MMP15 activation in any
of these three periods, indicating that ET-1 only regulates MMP15
levels (Supplementary data, Fig. S4).
In ﬁrst trimester placenta ETRA is located in VT, whereas ETRB is
predominantly located in EVT (Cervar-Zivkovic et al., 2011). Blocking
ETRB abolished the effect of ET-1 on MMP14 and 15 down-regulation.
Contrarily, ETRA blocking augmented this effect, likely due to a higher
fraction of ET-1 being bound to ETRB. These results argue for ETRB as
the major receptor through which ET-1 induced signals downregulate
MMP14 and MMP15.
We used two different assays to address the functional conse-
quences of ET-1 during the ﬁrst trimester of pregnancy. ET-1 induced
a down-regulation of both trophoblast outgrowth from chorionic villi
Figure 5 Low oxygen tension modulates the effect of ET-1 on MMP14 and MMP15 down-regulation: Primary trophoblasts (GW 7–11, n = 12)
were incubated under three different O2 tensions (1% O2, 2.5% O2 and 20% O2) in the absence (control) or presence of 100 nM ET-1 for 24 h; (A–C)
MMP14 (active form, act-MMP14) and MMP15 (pro-MMP15) protein levels were determined by Western blotting; (D) ET-1 levels were measured in
the supernatants from the controls by ELISA; Results were normalized to β-actin protein levels (A and B) or total protein (D) and calculated as fold
change relative to the controls (20% O2), arbitrarily set to 1; Data are representative for at least four experiments; *P < 0.05; **P ≤ 0.01; ***P ≤ 0.001.
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and trophoblast invasion. The ET-1 concentration (100 nM) used here
is similar to other studies assessing biological functions of ET-1
(Chakraborty et al., 2003). Higher ET-1 concentrations had an oppos-
ite effect, i.e. stimulated trophoblast invasion (Cervar-Zivkovic et al.,
2011), which is in line with the bimodal ET-1 effect observed in a var-
iety of cell systems (Cervar et al., 1996).
We have analyzed the additional effect of TNF-α on ET-1-mediated
MMP14 and 15 regulation. TNF-α is an important regulator of tropho-
blast invasion and is up-regulated in PE (Otun et al., 2011; Mihu et al.,
2015). While TNF-α alone did not change MMP14 and MMP15 pro-
tein, it enhanced the ET-1 effect on MMP15. Interestingly, TNF-α
increases ET-1 expression and vice versa (Zhao et al., 2005), suggesting
a complex interplay between ET-1 and inﬂammation, which in turn
might ﬁne-tune the trophoblast proteome.
Oxygen regulates MMP expression (Onogi et al., 2011). Placental
development during the ﬁrst trimester occurs in a low oxygen environ-
ment (2–3% O2) (James et al., 2006), and hypoxia (1% O2) is consid-
ered as one of the hallmarks of PE (Ouyang et al., 2009). We observed
lower MMP14 and MMP15 protein levels in primary trophoblasts
exposed to low oxygen tensions. Interestingly, oxygen also modulated
ET-1-mediated MMP14 and 15 down-regulation. Under 2.5% O2, only
MMP15 was down-regulated in the presence of ET-1, pointing that in
an in vivo oxygen environment, ET-1 might preferentially regulate
MMP15 than MMP14. Hypoxia (1% O2) abolished the effect of ET-1
on both MMPs. We conﬁrmed that an up-regulation of endogenous
ET-1 levels in trophoblasts might underlie this observation. The ET-1
promoter is highly responsive to hypoxia (Stow et al., 2011), which
might elevate ET-1 levels above its bimodal threshold, and thus act as
a negative feedback mechanism.
The major strength of the study is the use of primary human tropho-
blasts, which differ from ﬁrst trimester trophoblast cell lines in many
properties and also in their response to ET-1 (Bilban et al., 2000). The
main limitation of this study is the absence of an in-depth analysis of
ET-1 down-stream signaling. The effect of ET-1 on ETR levels was also
not characterized. This was not possible because of the limited
amount of ﬁrst trimester placental tissue available for trophoblast iso-
lation. Moreover, the effect of ET-1 on other factors involved in
trophoblast invasion cannot be ruled out.
Summary and conclusion
In the present study we have shown that ET-1, one of the molecules
up-regulated in PE, alters MMP14 and 15 expression via ETRB in ﬁrst
trimester trophoblasts, and impairs trophoblast functions such as
migration and invasion. Our results improve the current knowledge
about the molecular mechanisms underlying trophoblast invasion and
PE. We have also shown the importance of considering MMP14 and
15 regulation in a more complex environment, where other factors
such as inﬂammation or oxygen might act as modulators of this regula-
tion (Fig. 6). Modulation of the ET/ETR system in animal models of PE
is required to conﬁrm our ﬁndings in vivo and might open new thera-
peutic strategies for the management of this pathology.
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Supplementary data are available at http://humrep.oxfordjournals.
org/.
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